These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17084973)

  • 1. Atorvastatin slows down the deterioration of inner ear function with age in mice.
    Syka J; Ouda L; Nachtigal P; Solichová D; Semecký V
    Neurosci Lett; 2007 Jan; 411(2):112-6. PubMed ID: 17084973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
    Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
    Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
    Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin has distinct effects on endothelial markers in different mouse models of atherosclerosis.
    Nachtigal P; Jamborova G; Pospisilova N; Pospechova K; Solichova D; Zdansky P; Semecky V
    J Pharm Pharm Sci; 2006; 9(2):222-30. PubMed ID: 16959191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auditory efferent feedback system deficits precede age-related hearing loss: contralateral suppression of otoacoustic emissions in mice.
    Zhu X; Vasilyeva ON; Kim S; Jacobson M; Romney J; Waterman MS; Tuttle D; Frisina RD
    J Comp Neurol; 2007 Aug; 503(5):593-604. PubMed ID: 17559088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice.
    Yamada K; Sakurai E; Itaya M; Yamasaki S; Ogura Y
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1839-43. PubMed ID: 17389519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
    Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atorvastatin on progression of sensorineural hearing loss and tinnitus in the elderly: results of a prospective, randomized, double-blind clinical trial.
    Olzowy B; Canis M; Hempel JM; Mazurek B; Suckfüll M
    Otol Neurotol; 2007 Jun; 28(4):455-8. PubMed ID: 17529847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic effect of atorvastatin on autoimmune myocarditis is mediated by improving myocardial repolarization.
    Tang Q; Huang J; Qian H; Chen L; Wang T; Wang H; Shen D; Wu H; Xiong R
    Life Sci; 2007 Jan; 80(7):601-8. PubMed ID: 17217967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-mediated vasoconstriction in early atherosclerosis is markedly increased in ApoE-/- mouse but prevented by atorvastatin.
    Maguire JJ; Wiley KE; Kuc RE; Stoneman VE; Bennett MR; Davenport AP
    Exp Biol Med (Maywood); 2006 Jun; 231(6):806-12. PubMed ID: 16741003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration.
    Buttmann M; Lorenz A; Weishaupt A; Rieckmann P
    J Neurochem; 2007 Aug; 102(4):1001-8. PubMed ID: 17442054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib combined with atorvastatin prevents progression of atherosclerosis.
    Raval M; Frank PG; Laury-Kleintop L; Yan G; Lanza-Jacoby S
    J Surg Res; 2010 Oct; 163(2):e113-22. PubMed ID: 20538289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory and anti-thrombotic intervention strategies using atorvastatin, clopidogrel and knock-down of CD40L do not modify radiation-induced atherosclerosis in ApoE null mice.
    Hoving S; Heeneman S; Gijbels MJ; te Poele JA; Pol JF; Gabriels K; Russell NS; Daemen MJ; Stewart FA
    Radiother Oncol; 2011 Oct; 101(1):100-8. PubMed ID: 22001104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin.
    Kohno H; Sakai T; Saito S; Okano K; Kitahara K
    Exp Eye Res; 2007 Mar; 84(3):569-76. PubMed ID: 17208229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation.
    Stefanadi E; Tousoulis D; Antoniades C; Katsi V; Bosinakou E; Vavuranakis E; Triantafyllou G; Marinou K; Tsioufis C; Papageorgiou N; Latsios G; Stefanadis C
    Int J Cardiol; 2009 Apr; 133(2):266-8. PubMed ID: 18187214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis.
    Kuwahara N; Sasaki S; Kobara M; Nakata T; Tatsumi T; Irie H; Narumiya H; Hatta T; Takeda K; Matsubara H; Hushiki S
    Int J Cardiol; 2008 Jan; 123(2):84-90. PubMed ID: 17434618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging of cathepsin B proteolytic enzyme activity reflects the inflammatory component of atherosclerotic pathology and can quantitatively demonstrate the antiatherosclerotic therapeutic effects of atorvastatin and glucosamine.
    Kim DE; Kim JY; Schellingerhout D; Shon SM; Jeong SW; Kim EJ; Kim WK
    Mol Imaging; 2009; 8(5):291-301. PubMed ID: 19796606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
    Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y
    Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
    Goicoechea M; de Vinuesa SG; Lahera V; Cachofeiro V; Gómez-Campderá F; Vega A; Abad S; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S231-5. PubMed ID: 17130267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R; Mahajan M; Singh B; Bal BS; Kant R
    J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.